BioMarin Pharmaceutical Inc. (BMRN) Reports Q1 Loss of $0.04
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $62.27 -1.74%
EPS Growth %: +1,008.3%
Financial Fact:
Total operating expenses: 339.98M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +1,008.3%
Financial Fact:
Total operating expenses: 339.98M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) reported Q1 EPS of ($0.04), $0.06 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $109.46 million versus the consensus estimate of $103.8 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $97 at BMO Capital
- AutoZone beats profit view but misses on revenue
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
